Table 1.

Organ	Author	Phenotype (Hyper Acute Rejection)/AR/Chronic Allograft Injury	Study Size	nHLA antibody (nHLA-Ab)	References
	Bialic et al	chronic hemodialysis (pre-txp)	48	tubulin beta chain, vimentin, lamin-B1, and Rho GDP-dissociation inhibitor 2	[23]
Kidney	Sutherland et al	Acute Rejection	15	Protein Kinase Cζ	[8]
	Li et al	Chronic Allograft Injury	33	Angiotensinogen (AGT) and Speedy homologue A (SPDYA)	[14]
	Li et al	Acute Rejection	15	MICA	[7]
	Li et al	Post-transplant Ab response	18	IgG's against 5,056 unique protein targets	[10]
	Butte et al	ESRD	95	angiotensinogen and PRKRIP1
	Sigdel et al	Chronic Allograft Injury	98	MIG (CXCL9), ITAC (CXCL11), IFN-γ, glial-derived neurotrophic factor	[13]
	Chaudhuri et al	Acute Rejection	124	MICA	[36]
	Dragun et al	Refractory vascular rejection (AR)	33	Angiotensin II type 1 receptor antibody	[33]
	Dinavahi et al	Chronic Allograft Injury	39	peroxisomal-trans-2-enoyl-coA-reductase	[47]
	Zou et al	Acute Rejection	1910	MICA	[35]
	Narayan et al	Acute Rejection	1		[34]
	Jackson et al	Acute Rejection	60	anti-endothelial cell antibodies (AECAs)	[30]
	Breimer et al	Rejection	147		[32]
	Sun et al	Acute Rejection	226		[49]
Heart	Ismail et al	Acute Rejection	60		[50]
	Fredrich et al	cardiac allograft vasculopathy (CAV)	80		[31]
	Acevedo et al	Cardiac allograft vasculopathy (CAV)	48	anti-hnRNP-K antibodies	[40]
Lung	Smith et al	Hyperacute rejection, Acute rejection	616	IgM Abs to nHLAs	[15]
	Otten et al	Bronchiolitis obliterans syndrome (BOS)	11	PSMC4, F3, LOC284058, PLUNC, ZNF33A, XP_931864	[51]
	Jaramillo et al	Bronchiolitis obliterans syndrome (BOS)	27	anti-AEC Abs	[41]
	Goers et al	Bronchiolitis obliterans syndrome (BOS)	36	anti-K-alpha1 tubulin Abs	[42]
	Tiriveedhi et al	Bronchiolitis obliterans syndrome (BOS)	N/A	anti-K-alpha1 tubulin Abs	[43]
	Burlingham et al	Bronchiolitis obliterans syndrome (BOS)		collagen V	[44]
	Tirivedhi et al	Bronchiolitis obliterans syndrome (BOS)	12	collagen V epitopes	[45]
Liver	Sumitran-Holgersson et al	Rejection	95	Liver sinusoidal endothelial cells (LSECs)	[37]
BMT	Wadia et al	GVHD	190	NuSAP1, CHAF1b	[46]
	Porcheray et al	Rejection/tolerance	5	PSMA4	[52]

N/A* in vitro cell culture